Back to today’s briefing

Story perspectives

Trump's Funding Cuts Disrupt NIH Trials, Impacting 74,000

11/19/2025

35 3 Full Breakdown

Summary

Story summary

In 2025, nearly 4% of NIH-funded trials lost funding from grant terminations initiated by U.S. President Donald Trump, affecting over 74,000 participants.
Disruptions mainly affected infectious diseases, prevention, and behavioral interventions.
Gender-affirming care research saw a major decline, with 64.1% of related grants halted.
383 of 11,008 active trials lost funding, and the Northeast region reported the highest termination rate.

1 of 1

Story summary

In 2025, nearly 4% of NIH-funded trials lost funding from grant terminations initiated by U.S. President Donald Trump, affecting over 74,000 participants.
Disruptions mainly affected infectious diseases, prevention, and behavioral interventions.
Gender-affirming care research saw a major decline, with 64.1% of related grants halted.
383 of 11,008 active trials lost funding, and the Northeast region reported the highest termination rate.